Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 58

    1.

    Passive cigarette smoke exposure during various periods of life, genetic variants, and breast cancer risk among never smokers.

    Anderson LN, Cotterchio M, Mirea L, Ozcelik H, Kreiger N.

    Am J Epidemiol. 2012 Feb 15;175(4):289-301. Epub 2012 Jan 12.

    PMID:
    22247046
    [PubMed - indexed for MEDLINE]
    2.

    Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer.

    Andre F, Conforti R, Moeder CB, Mauguen A, Arnedos M, Berrada N, Delaloge S, Tomasic G, Spielmann M, Esteva FJ, Rimm DL, Michiels S.

    Ann Oncol. 2012 Jan 11. [Epub ahead of print]

    PMID:
    22241898
    [PubMed - as supplied by publisher]
    3.

    NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study.

    de Kruijf EM, Sajet A, van Nes JG, Putter H, Smit VT, Eagle RA, Jafferji I, Trowsdale J, Liefers GJ, van de Velde CJ, Kuppen PJ.

    BMC Cancer. 2012 Jan 18;12:24.

    PMID:
    22257486
    [PubMed - in process]
    Free PMC Article
    4.

    Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.

    Mohammed ZM, McMillan DC, Elsberger B, Going JJ, Orange C, Mallon E, Doughty JC, Edwards J.

    Br J Cancer. 2012 Jan 17;106(2):383-8. doi: 10.1038/bjc.2011.569. Epub 2012 Jan 3.

    PMID:
    22251968
    [PubMed - indexed for MEDLINE]
    5.

    Phase I study of lapatinib plus vinorelbine in patients with locally advanced or metastatic breast cancer overexpressing HER2.

    Brain E, Isambert N, Dalenc F, Diéras V, Bonneterre J, Rezai K, Jimenez M, Mefti-Lacheraf F, Cottura E, Tresca P, Vanlemmens L, Mahier-Aït Oukhatar C, Lokiec F, Fumoleau P.

    Br J Cancer. 2012 Feb 14;106(4):673-7. doi: 10.1038/bjc.2011.591. Epub 2012 Jan 12.

    PMID:
    22240778
    [PubMed - indexed for MEDLINE]
    6.

    Sentinel lymph node biopsy in patients with breast cancer using superparamagnetic iron oxide and a magnetometer.

    Shiozawa M, Lefor AT, Hozumi Y, Kurihara K, Sata N, Yasuda Y, Kusakabe M.

    Breast Cancer. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22240965
    [PubMed - as supplied by publisher]
    7.

    Delivery of MicroRNA-10b with Polylysine Nanoparticles for Inhibition of Breast Cancer Cell Wound Healing.

    Jin H, Yu Y, Chrisler WB, Xiong Y, Hu D, Lei C.

    Breast Cancer (Auckl). 2012;6:9-19. Epub 2011 Dec 7.

    PMID:
    22259248
    [PubMed - in process]
    Free PMC Article
    8.

    Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.

    Qi JP, Yang YL, Zhu H, Wang J, Jia Y, Liu N, Song YJ, Zan LK, Zhang X, Zhou M, Gu YH, Liu T, Hicks DG, Tang P.

    Breast Cancer (Auckl). 2012;6:1-8. Epub 2011 Dec 6.

    PMID:
    22259247
    [PubMed - in process]
    Free PMC Article
    9.

    MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.

    Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH.

    Breast Cancer Res. 2012 Jan 18;14(1):R14. [Epub ahead of print]

    PMID:
    22251626
    [PubMed - as supplied by publisher]
    10.

    Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.

    Bundred NJ, Kenemans P, Yip CH, Beckmann MW, Foidart JM, Sismondi P, Schoultz BV, Vassilopoulou-Sellin R, Galta RE, Lieshout EV, Mol-Arts M, Planellas J, Kubista E.

    Breast Cancer Res. 2012 Jan 17;14(1):R13. [Epub ahead of print]

    PMID:
    22251615
    [PubMed - as supplied by publisher]
    11.

    MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.

    Lappano R, Santolla MF, Pupo M, Sinicropi MS, Caruso A, Rosano C, Maggiolini M.

    Breast Cancer Res. 2012 Jan 17;14(1):R12. [Epub ahead of print]

    PMID:
    22251451
    [PubMed - as supplied by publisher]
    12.

    Molecular profiling of patient-derived breast cancer xenografts.

    Reyal F, Guyader C, Decraene C, Lucchesi C, Auger N, Assayag F, De Plater L, Gentien D, Poupon MF, Cottu P, De Cremoux P, Gestraud P, Vincent-Salomon A, Fontaine JJ, Roman-Roman S, Delattre O, Decaudin D, Marangoni E.

    Breast Cancer Res. 2012 Jan 16;14(1):R11. [Epub ahead of print]

    PMID:
    22247967
    [PubMed - as supplied by publisher]
    13.

    Phase II trial of temsirolimus in patients with metastatic breast cancer.

    Fleming GF, Ma CX, Huo D, Sattar H, Tretiakova M, Lin L, Hahn OM, Olopade FO, Nanda R, Hoffman PC, Naughton MJ, Pluard T, Conzen SD, Ellis MJ.

    Breast Cancer Res Treat. 2012 Jan 13. [Epub ahead of print]

    PMID:
    22245973
    [PubMed - as supplied by publisher]
    14.

    Adiposity and risk of proliferative diseases of the breast prior to the diagnosis of invasive breast cancer: results from a pilot study.

    Stahl MS, Prichard J, Stark A.

    Breast J. 2012 Mar-Apr;18(2):191-4. doi: 10.1111/j.1524-4741.2011.01213.x. Epub 2012 Jan 12. No abstract available.

    PMID:
    22239059
    [PubMed - in process]
    15.

    Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors.

    Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27389. [Epub ahead of print]

    PMID:
    22252966
    [PubMed - as supplied by publisher]
    16.

    Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: Risk factors of IBTR and validation of the M. D. Anderson Prognostic Index.

    Ishitobi M, Ohsumi S, Inaji H, Ohno S, Shigematsu H, Akiyama F, Iwase T, Akashi-Tanaka S, Sato N, Takahashi K, Oura S.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.27377. [Epub ahead of print]

    PMID:
    22252882
    [PubMed - as supplied by publisher]
    17.

    Routine clinical use of the one-step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients: Results of a multicenter study in Japan.

    Tamaki Y, Sato N, Homma K, Takabatake D, Nishimura R, Tsujimoto M, Yoshidome K, Tsuda H, Kinoshita T, Kato H, Taniyama K, Kamio T, Nakamura S, Akiyama F, Noguchi S; and the Japanese One-Step Nucleic Acid Amplification Study Group.

    Cancer. 2012 Jan 17. doi: 10.1002/cncr.26683. [Epub ahead of print]

    PMID:
    22252672
    [PubMed - as supplied by publisher]
    18.

    The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients.

    Walko CM, Combest AJ, Spasojevic I, Yu AY, Bhushan S, Hull JH, Hoskins J, Armstrong D, Carey L, Collicio F, Dees EC.

    Cancer Chemother Pharmacol. 2012 May;69(5):1189-96. Epub 2012 Jan 15.

    PMID:
    22245954
    [PubMed - in process]
    19.

    70-Gene classifier for differentiation between paclitaxel- and docetaxel-sensitive breast cancers.

    Naoi Y, Tanei T, Kishi K, Tsunashima R, Tominaga N, Baba Y, Nakayama T, Shimazu K, Kim SJ, Tamaki Y, Noguchi S.

    Cancer Lett. 2012 Jan 28;314(2):206-12. Epub 2011 Oct 1.

    PMID:
    22018777
    [PubMed - indexed for MEDLINE]
    20.

    CD24 promotes tumor cell invasion by suppressing tissue factor pathway inhibitor-2 (TFPI-2) in a c-Src-dependent fashion.

    Bretz N, Noske A, Keller S, Erbe-Hofmann N, Schlange T, Salnikov AV, Moldenhauer G, Kristiansen G, Altevogt P.

    Clin Exp Metastasis. 2012 Jan;29(1):27-38. Epub 2011 Oct 8.

    PMID:
    21984372
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk